E-LIB Suche - Ergebnisse für: Pisetsky, David S.

1

Evaluation of Type 2 SLE symptoms in patients with a range ..:

Rogers, Jennifer L. ; Clowse, Megan E. B. ; Pisetsky, David S....
Clinical Rheumatology. 43 (2024) 4 - p. 1319-1326 , 2024

Link: https://doi.org/10.1007/..

2

DNA corona on nanoparticles leads to an enhanced immunostim..:

Anees, Faisal ; Montoya, Diego A. ; Pisetsky, David S..
Proceedings of the National Academy of Sciences. 121 (2024) 11 - p. , 2024

Link: https://doi.org/10.1073/..

3

2023 International Consensus Guidance for the use of Tripte..:

Zhang, Xuan ; Xia, Jun ; Jiang, Ying...
Journal of Autoimmunity. 142 (2024) - p. 103148 , 2024

Link: https://doi.org/10.1016/..

4

The Binding Properties of Antibodies to Z-DNA in the Sera o..:

Pisetsky, David S. ; Gedye, Matthew J. ; David, Lawrence A..
International Journal of Molecular Sciences. 25 (2024) 5 - p. 2556 , 2024

Link: https://doi.org/10.3390/..

5

The Type 1 & 2 systemic lupus erythematosus model: Perspect..:

Eudy, Amanda M ; Clowse, Megan EB ; Corneli, Amy...
Lupus. 33 (2024) 3 - p. 266-272 , 2024

Link: https://doi.org/10.1177/..

6

Moonlighting chromatin: when DNA escapes nuclear control:

Singh, Jeeshan ; Boettcher, Michael ; Dölling, Maximilian...
Cell Death & Differentiation. 30 (2023) 4 - p. 861-875 , 2023

Link: https://doi.org/10.1038/..

7

Pathogenesis of autoimmune disease:

Pisetsky, David S.
Nature Reviews Nephrology. , 2023

Link: https://doi.org/10.1038/..

8

Antibodies to Neutrophil Extracellular Traps: Novel Markers..:

Pisetsky, David S.
Arthritis & Rheumatology. 75 (2023) 8 - p. 1331-1333 , 2023

Link: https://doi.org/10.1002/..

9

Development and psychometric evaluation of a physician glob..:

Clowse, Megan E B ; Rogers, Jennifer L ; Coles, Theresa...
Lupus Science & Medicine. 10 (2023) 2 - p. e001016 , 2023

Link: https://doi.org/10.1136/..

10

The expression of antibodies to Z-DNA in the blood of patie..:

Spencer, Diane M. ; Svenungsson, Elisabet ; Gunnarsson, Iva..
Clinical Immunology. 255 (2023) - p. 109763 , 2023

Link: https://doi.org/10.1016/..

11

Using PROMIS-29 to determine symptom burdens in the context..:

Sun, Kai ; Eudy, Amanda M. ; Harris, Nathaniel...
Journal of Patient-Reported Outcomes. 7 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

12

Intermittent and Persistent Type 2 lupus: patient perspecti..:

Eudy, Amanda M ; Rogers, Jennifer L ; Corneli, Amy...
Lupus Science & Medicine. 9 (2022) 1 - p. e000705 , 2022

Link: https://doi.org/10.1136/..

13

The use of patient-reported outcome measures to classify ty..:

Eudy, Amanda M ; Reeve, Bryce B ; Coles, Theresa...
Lupus. 31 (2022) 6 - p. 697-705 , 2022

Link: https://doi.org/10.1177/..

14

Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibit..:

Wallace, Daniel J. ; Dörner, Thomas ; Pisetsky, David S....
ACR Open Rheumatology. 5 (2022) 1 - p. 38-48 , 2022

Link: https://doi.org/10.1002/..

15

Mixed-surface polyamidoamine polymer variants retain nuclei..:

Olson, Lyra B. ; Hunter, Nicole I. ; Rempel, Rachel E....
iScience. 25 (2022) 12 - p. 105542 , 2022

Link: https://doi.org/10.1016/..